A Phase Ib, Open‐Label Study of Dalantercept, an Activin Receptor‐Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular Carcinoma
2018 ◽
Vol 24
(2)
◽
pp. 161
◽
Ghassan K. Abou‐Alfa
◽
Rebecca A. Miksad
◽
Mohamedtaki A. Tejani
◽
Stephen Williamson
◽
Martin E. Gutierrez
◽
...
2012 ◽
Vol 56
(2)
◽
pp. 486-487
◽
Jairo A. Garcia
◽
Lewis R. Roberts
2015 ◽
Vol 62
◽
pp. S856-S857
◽
P. Merle
◽
G. Pelletier
◽
F. Habersetzer
◽
G. Luca Frassineti
◽
G.-P. Pageaux
◽
...
2008 ◽
Vol 115
(2)
◽
pp. 428-436
◽
Thomas Yau
◽
Pierre Chan
◽
Kelvin K. Ng
◽
Sin Ho Chok
◽
Tan To Cheung
◽
...
2016 ◽
Vol 11
(2)
◽
pp. 199-208
◽
Shi-Ming Lin
◽
Sheng-Nan Lu
◽
Ping-Tsung Chen
◽
Long-Bin Jeng
◽
Shinn-Cherng Chen
◽
...
2016 ◽
Vol 34
(15_suppl)
◽
pp. TPS4146-TPS4146
◽
Ghassan K. Abou-Alfa
◽
Peter R. Galle
◽
Yee Chao
◽
Karen T. Brown
◽
Jeong Heo
◽
...
2012 ◽
Vol 18
(7)
◽
pp. 2090-2098
◽
Richard S. Finn
◽
Yoon-Koo Kang
◽
Mary Mulcahy
◽
Blase N. Polite
◽
Ho Yeong Lim
◽
...
Ying-Hong Shi
◽
Yuan Ji
◽
Wei-Ren Liu
◽
Yan-Rui Pang
◽
Zhen-Bin Ding
◽
...
2011 ◽
Vol 17
(7)
◽
pp. 1973-1983
◽
Joong-Won Park
◽
Richard S. Finn
◽
Jun Suk Kim
◽
Mark Karwal
◽
Ruby K. Li
◽
...
B. Sangro
◽
K. Numata
◽
Y. Huang
◽
C. Gomez-Martin
◽
A. Hiraoka
◽
...